NCT03122028View on ClinicalTrials.gov

Clinical Investigation of the LAmbre Left Atrial Appendage Closure System

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 5, 2013

Primary Completion Date

March 9, 2016

Study Completion Date

November 9, 2016

Conditions
Atrial Fibrillation
Interventions
DEVICE

LAA closure system

Patients with non-valvular paroxymal, persistent or permanent atrial fibrillation with long-term sustainability and cannot be treated with anticoagulation and scheduled for interventional left atrial appendage closure.

All Listed Sponsors
lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY

NCT03122028 - Clinical Investigation of the LAmbre Left Atrial Appendage Closure System | Biotech Hunter | Biotech Hunter